Observational studyGerman medical science : GMS e-journal2025

Somatic mutation counts as a surrogate marker for tumor mutation burden to predict progesterone receptor-positive (PR+) status in PIK3CA-mutated breast cancer.

Bandana Kumari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.